Heart disease remained among the leading causes of death, even amid the COVID-19 pandemic, which may have exacerbated preexisting CVD morbidity-related racial/ethnic disparities, researchers reported.
In 2020, more than 3.3 million deaths were registered in the U.S., which exceeded the 2019 figure by more than 500,000 deaths, according to the American Heart Association’s annual Heart Disease and Stroke Statistics update. Read more in Healio.
January 25, 2023 – Researchers at the Children’s Hospital of Philadelphia (CHOP) have developed an application to automate the determination of engraftment, a key outcome after hematopoietic stem cell transplants.
The tool, described in a recent study published in Transplantation and Cellular Therapy, was designed by hematopoietic cell transplant and informatics experts at CHOP to help improve transplant outcomes reporting. According to the press release, the standard method to reduce errors in these reports is a tedious, manual process that is not always effective. Read more in Health IT Analytics.
JANUARY, 26, 2023
Guide Helps Transplant Centers Continue the Evolution from Endomyocardial Biopsies to Noninvasive Surveillance Using AlloMap GEP and AlloSure dd-cfDNA
BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Journal of the American College of Cardiology (JACC): Heart Failure has published a detailed guide1 to help clinicians transition from routine invasive endomyocardial biopsy (EMB) to a less invasive acute rejection monitoring protocol in clinical practice.
Depression and anxiety in young adults are associated with less ideal CV health, which may be improved with a better diet, physical activity and improved sleep, researchers reported.
“Mechanisms linking mental health and cardiovascular health are likely multifactorial. Read more in Healio.
Infliximab induction therapy fails to protect kidney transplants and appears to increase the risk of BK virus infection in recipients, investigators report.
Peter Heeger, MD, of the Comprehensive Transplant Center at Cedars Sinai Medical Center in West Hollywood, California, and colleagues randomly assigned 225 unsensitized recipients of deceased-donor kidneys to receive intravenous infliximab (3 mg/kg) or saline placebo prior to kidney reperfusion. Read the full story in Renal & Urology News.
Study demonstrates that a novel technique for regenerating donor lungs can increase the number of organs available for life-saving transplantation
NEW YORK, Jan. 23, 2023 /PRNewswire/ — A novel method for supporting and recovering donor lungs outside the body shows potential to increase the number of organs available for transplant, according to a recent study published in The Journal of Heart and Lung Transplantation. Read the complete press release on Yahoo.com.
Kristal Higgins just wants to be healthy, become a nurse and travel to Greece. But she has kidney failure and has been on a transplant waiting list for six years.
The disease and its comorbidities have touched many of her loved ones. Her mother has stage 2 kidney disease. Her father is diabetic, a risk factor for kidney failure, as was her late grandmother. Several of her relatives have kidney failure. Read more in USA Today.
In Florida, demand has never been higher.
Ten hospitals in the state perform heart transplants, each with their own criteria. As the year kicks off, more than 200 people are on the wait list, according to the Organ Procurement Transplantation Network. Read more in Medical Xpress.
Published: January 20, 2023 (see history)
Cite this article as: Mehta J, Ndubueze O, Tatum D, et al. (January 20, 2023) Kidney Transplant Outcomes in Recipients Over the Age of 70. Cureus 15(1): e34021. doi:10.7759/cureus.34021
Background: Patients older than 70 years are the fastest-growing age group of patients requiring renal replacement therapy. This has resulted in a corresponding increase in the number of elderly transplant recipients. We hypothesized that graft survival in this population would be comparable to that seen in the literature on kidney transplant recipients under 70 years of age. Read the complete abstract in Cureus.
U.S. adults who reported a history of migraine or severe headache were 25% more likely to develop hypertension compared with those with no migraine history, with a higher risk for women vs. men, researchers reported. Read more in Healio.